‘Tomudex’ (raltitrexed) 4.0 mg/m[2] as second- or third-line therapy in patients with advanced colorectal cancer: a Phase II study
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S75-75
- https://doi.org/10.1016/s0959-8049(99)80667-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: